DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages

Translate

Hibernoma

Authors: Riyad NH Seervai and Claire Jordan Wiggins, Medical Students, Baylor College of Medicine, Houston, Texas, USA. DermNet NZ Editor in Chief: Adjunct A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy edited by Gus Mitchell. June 2020.


toc-icon

Submit your photo of hibernoma

What is hibernoma?

Hibernoma, also known as fetal lipoma or lipoma of embryonic fat, is a rare subtype of benign lipomatous tumour derived from brown fat. It was first reported as a ‘pseudolipoma’ (a ‘peculiar fat tumour’) by Merkel in 1906 [1] and was given its name by Gery in 1914 for its resemblance to brown fat found in hibernating animals [2].

What causes hibernoma?

The main function of brown adipose tissue is non-shivering thermogenesis (‘burning’ fat), which it accomplishes through fatty-acid dependent uncoupling of adenosine triphosphate (ATP) production in the mitochondria via the uncoupling protein UCP1 [3]. Brown fat deposits are typically found in infants [4,5], and were believed to disappear during adulthood [6,7]. However, several reports indicate the existence of brown fat in adults [8–10], with debate over whether these deposits constitute classical brown fat or are ‘beige’ fat [11,12]. Continuous growth of these vestiges of brown fat lead to the formation of a hibernoma.

Hibernoma is associated with chromosomal rearrangements in the long arm of chromosome 11 (11q13-21), which includes the multiple endocrine neoplasia type 1 (MEN1) region [13–15].

Loss of AIP and MEN1 genes are considered to be essential for hibernoma development [16]. There are reports of hibernoma in patients with multiple endocrine neoplasia type 1 (MEN1) syndrome [17]. However, the cytogenetic pattern seen in hibernoma differs from those seen in MEN1-associated tumours and it is believed they progress via different mechanisms [15].

Two isolated cases of hibernoma have been reported with high expression of TP53, with the authors speculating that inactivation of the protein may be important for their development [18].

Who gets hibernoma?

Hibernomas are rare, comprising ~1% of all adipocytic tumours [19]. They occur in the third to fourth decade of life (the mean age of onset is 38) and they are uncommon in children. They are more common in men [20].

What are the clinical features of hibernomas?

Hibernoma presents as a progressive, slow-growing, painless subcutaneous mass [19]. The most common locations for hibernoma include the thigh, shoulder, back, neck, chest, arm, and retroperitoneum [20]. Other locations include the breast, [21,22], larynx [23], pleura [24], pelvis [25], vulva [26], and scrotum [27,28]. Approximately 10% of hibernomas are intramuscular [20].

What are the complications of hibernomas?

Complications of hibernoma are related to the rapid tumour growth and infiltration of neighbouring structures. Pressure on nerves can result in neuropathic pain.

  • A 36-year-old patient presented with carpal tunnel syndrome due to a hibernoma in the wrist [29].
  • A 55-year-old man had thoracic outlet syndrome from intrathoracic extension of an axillary hibernoma [30].
  • Sciatic neuropathy has been reported in a patient with a giant (27 cm) hibernoma of the thigh [31].
  • An intraosseous hibernoma is typically an incidental finding after a patient presents with back pain (vertebral hibernoma) or knee pain (femoral hibernoma) [32,33].
  • Mediastinal hibernoma was reported as the cause of chronic cough in a 33-year-old female [34].

How is hibernoma diagnosed?

Radiographic imaging is used when considering a diagnosis of hibernoma [19,35].

  • Computed tomography (CT) shows well-circumscribed mass with attenuation intermediate between subcutaneous fat and skeletal muscle.
  • Magnetic resonance imaging (MRI) shows well-circumscribed mass slightly hypointense to fat on T1- and T2- weighted images.
  • 18F-fluorodeoxyglucose (FDG) PET/CT shows high uptake due to high metabolic activity of brown adipocytes, with change in avidity on follow-up. Uptake values are often higher compared to liposarcoma.

The diagnosis of hibernoma is confirmed by histopathology on biopsy or excision.

  • Hibernoma is a well-circumscribed, encapsulated, soft/rubbery mass that varies from yellow to red-brown when cut.
  • Light microscopy shows typical hibernoma cells: multivacuolated brown fat cells with eosinophilic, slightly granular cytoplasm, a small central nucleus, and a single prominent nucleolus with evenly dispersed chromatin. These cells express high levels of cytoplasmic UCP1 [36].

There are four hibernoma variants [20].

Typical lobular hibernoma

The lobular hibernoma is the most common variant (82%), which appears as a mixture of pale cells, hibernoma cells, and eosinophilic cells.

  • The pale cell subtype has mostly pale, multivacuolated cells mixed with univacuolated adipocytes. This type is more common on the thigh and is most commonly intramuscular.
  • The mixed cell subtype has equal numbers of pale and eosinophilic multivacuolated cells. This type is more common on the trunk.
  • The eosinophilic subtype has a predominance of eosinophilic multivacuolated cells. This is more common on the upper extremities.

Myxoid hibernoma

A myxoid hibernoma contains a loose basophilic matrix and foamy histiocytes. It is more common in men and in the head and neck region (including the scalp and shoulder).

Lipoma-like hibernoma

Lipoma-like hibernoma has univacuolated white adipocytes with scattered hibernoma cells. It arises most commonly in the thigh.

Spindle cell hibernoma

Spindle cell hibernoma is the least common variant, accounting for 2% of hibernomas. It has features of spindle cell lipoma and hibernoma. Histology shows hibernoma cells, CD34+ spindle cells, thick collagen bundles, mast cells, myxoid stroma, and mature adipocytes. It is found on the scalp and posterior neck.

What is the differential diagnosis for hibernoma?

The differential diagnosis for hibernoma includes benign and malignant tumours [19,35].

Benign soft tissue tumours

Benign soft tissue tumours that could be interpreted as hibernoma include:

  • Lipoma — a homogenous mass with no contrast enhancement on imaging
  • Haemangioma — calcifications, T2-hyperintensity, and internal vasculature forming a lump under the skin
  • Angiolipoma — T2-hyperintensity and internal vasculature forming a lump under the skin.

Malignant soft tissue tumours

Malignant soft tissue tumours that could be interpreted as hibernoma include:

  • Well-differentiated liposarcoma — presents with thickened septa, decreased vascularity, and areas of T2-hyperintensity
  • Myxoid liposarcoma — a malignant tumour with t(12;16) translocation and characteristic branching vascularisation
  • Rhabdomyosarcoma — a malignant and aggressive cancer associated with bone destruction
  • Lymphoma — isoattenuated (weakened to the same degree as background tissue) CT pattern.

What is the treatment for hibernoma?

The definitive treatment for hibernoma is complete surgical resection [19]. Since hibernomas are almost never malignant [37], no treatment is required if the patient is asymptomatic.

What is the outcome for hibernoma?

Hibernomas are typically benign, and recurrence is rare after complete excision [19].

 

References

  1. Merkel H. On a Pseudolipoma of the Breast (Peculiar Fat Tumor). Beitr Pathol Anat 1906; 39: 152–7.
  2. Gery L. Discussions. Bull Mem Soc Anat (Paris) 1914; 89: 111–23.
  3. Fedorenko A, Lishko PV, Kirichok Y. Mechanism of Fatty-Acid-Dependent Ucp1 Uncoupling in Brown Fat Mitochondria. Cell 2012; 151: 400–13. DOI: 10.1016/j.cell.2012.09.010. PubMed
  4. Merklin RJ. Growth and Distribution of Human Fetal Brown Fat. Anat Rec 1974; 178: 637–45. DOI: 10.1002/ar.1091780311. PubMed
  5. Heaton JM. The Distribution of Brown Adipose Tissue in the Human. J Anat 1972; 112: 35–9. PubMed Central
  6. Cunningham S, Leslie P, Hopwood D, et al. The Characterization and Energetic Potential of Brown Adipose Tissue in Man. Clin Sci (Lond) 1985; 69: 343–8. DOI: 10.1042/cs0690343. PubMed
  7. Lean ME. Brown Adipose Tissue in Humans. Proc Nutr Soc 1989; 48: 243–56. DOI: 10.1079/pns19890036. PubMed
  8. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, et al. Cold-Activated Brown Adipose Tissue in Healthy Men. N Engl J Med 2009; 360: 1500–8. DOI: 10.1056/NEJMoa0808718. PubMed
  9. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009 Apr 9;360(15):1509-17. doi: 10.1056/NEJMoa0810780. PMID: 19357406; PMCID: PMC2859951. PubMed
  10. Virtanen KA, Lidell ME, Orava J, Heglind M, et al. Functional Brown Adipose Tissue in Healthy Adults. N Engl J Med 2009; 360: 1518–25. DOI: 10.1056/NEJMoa0808949. PubMed
  11. Cypess AM, White AP, Vernochet C, Schulz TJ, et al. Anatomical Localization, Gene Expression Profiling and Functional Characterization of Adult Human Neck Brown Fat. Nat Med 2013; 19: 635–9. DOI: 10.1038/nm.3112. PubMed
  12. Lidell ME, Betz MJ, Dahlqvist Leinhard O, Heglind M, et al. Evidence for Two Types of Brown Adipose Tissue in Humans. Nat Med 2013; 19: 631–4. DOI: 10.1038/nm.3017. PubMed
  13. Mertens F, Rydholm A, Brosjö O, Willén H, et al. Hibernomas Are Characterized by Rearrangements of Chromosome Bands 11q13-21. Int J Cancer 1994; 58: 503–5. DOI: 10.1002/ijc.2910580408. PubMed Central
  14. Mrózek K, Karakousis CP, Bloomfield CD. Band 11q13 Is Nonrandomly Rearranged in Hibernomas. Genes Chromosomes Cancer 1994; 9: 145–7. DOI: 10.1002/gcc.2870090212. PubMed
  15. Gisselsson D, Höglund M, Mertens F, Dal Cin P, Mandahl N. Hibernomas Are Characterized by Homozygous Deletions in the Multiple Endocrine Neoplasia Type I Region. Metaphase Fluorescence in Situ Hybridization Reveals Complex Rearrangements Not Detected by Conventional Cytogenetics. Am J Pathol 1999; 155: 61–6. DOI: 10.1016/s0002-9440(10)65099-7. PubMed
  16. Nord KH, Magnusson L, Isaksson M, Nilsson J, et al. Concomitant Deletions of Tumor Suppressor Genes Men1 and Aip Are Essential for the Pathogenesis of the Brown Fat Tumor Hibernoma. Proc Natl Acad Sci USA 2010; 107: 21122–7. DOI: 10.1073/pnas.1013512107. PubMed
  17. Hedayati V, Thway K, Thomas JM, Moskovic E. Men1 Syndrome and Hibernoma: An Uncommonly Recognised Association? Case Rep Med 2014; 2014: 804580. DOI: 10.1155/2014/804580. PubMed
  18. Lele SM, Chundru S, Chaljub G, Adegboyega P, Haque AK. Hibernoma: A Report of 2 Unusual Cases with a Review of the Literature. Arch Pathol Lab Med 2002; 126: 975–8. DOI: 10.1043/0003-9985(2002)126<0975:H>2.0.Co;2. PubMed
  19. Mavrogenis AF, Coll-Mesa L. Soft Tissue: Hibernomas. Atlas Genet Cytogenet Oncol Haematol 2013; 17: 60–4. DOI: https://doi.org/10.4267/2042/48474. Journal
  20. Furlong MA, Fanburg-Smith JC, Miettinen M. The Morphologic Spectrum of Hibernoma: A Clinicopathologic Study of 170 Cases. Am J Surg Pathol 2001; 25: 809–14. DOI: 10.1097/00000478-200106000-00014. PubMed
  21. Neves Filho EHC, Lima GAF, Alves  RM, Sousa VM, Cunha M. Mammary Hibernoma: A Case Report of a Rare Disease. Rev Bras Ginecol Obstet 2018; 40: 232–4. DOI: 10.1055/s-0038-1639500. PubMed
  22. Riley MP, Karamchandani DM. Mammary Hibernoma: A Rare Entity. Arch Pathol Lab Med 2015; 139: 1565–7. DOI: 10.5858/arpa.2014-0318-RS. Journal
  23. Minni A, Barbaro M, Vitolo D, Filipo R. Hibernoma of the Para-Glottic Space: An Unusual Tumour of the Larynx. Acta Otorhinolaryngol Ital 2008; 28: 141–3. PubMed
  24. Marchiori E, Zanetti G, Hochhegger B. Hibernoma: An Uncommon Cause of a Pleural Mass. J Bras Pneumol 2015; 41: 103–4. DOI: 10.1590/s1806-37132015000100015. PubMed Central
  25. Dulskas A, Poskus E, Jurevicius S, Strupas K. Giant gluteal lipoma presenting as a sciatic hernia. Hernia 2013. DOI: 10.1007/s10029-013-1184-6. PubMed
  26. Sheth A, Terzic M, Arsenovic N. Vulvar Hibernoma. Indian J Pathol Microbiol 2011; 54: 817–8. DOI: 10.4103/0377-4929.91532. PubMed
  27. Hayashida M, Yano A, Nagamoto S, Sakaguchi K, et al. Intrascrotal Hibernoma Mimicking Liposarcoma: A Case Study. Urol Case Rep 2020; 32: 101206. DOI: 10.1016/j.eucr.2020.101206. PubMed
  28. Sayrak H, Gönül E, Sayrak F. Hibernoma in the Scrotum. Br J Urol 1997; 80: 679–80. DOI: 10.1046/j.1464-410x.1997.00321.x. PubMed
  29. Bouya A, Tibouda M, Jaafar A. Carpal Tunnel Syndrome Due to Hibernoma of the Wrist: Case Report. Hand Surg Rehabil 2019; 38: 79–81. DOI: 10.1016/j.hansur.2018.10.241. PubMed
  30. Klinkenberg TJ, Wolf RFE, Bouma W, Suurmeijer AJH, Mariani MA. Axillary Chest Wall Hibernoma with Intrathoracic Extension Presenting as Thoracic Outlet Syndrome. J Thorac Imaging 2019; 34: W10–2. DOI: 10.1097/rti.0000000000000376. PubMed
  31. Ersozlu S, Sahin O, Ozgur AF, Akkaya T. Sciatic Neuropathy from a Giant Hibernoma of the Thigh: A Case Report. Am J Orthop (Belle Mead NJ) 2008; 37: E103–6. PubMed
  32. Jerman A, Snoj Ž, Kuzmanov BG, Limpel Novak AK. Intraosseous Hibernoma: Case Report and Tumor Characterization. BJR Case Rep 2015; 1: 20150204. DOI: 10.1259/bjrcr.20150204. PubMed
  33. Song B, Ryu HJ, Lee C, Moon KC. Intraosseous Hibernoma: A Rare and Unique Intraosseous Lesion. J Pathol Transl Med 2017; 51: 499–504. DOI: 10.4132/jptm.2017.07.28. PubMed
  34. Muñoz-Palacio BJ, Figueroa S, Matute G, Garcia-Mejía C, Betancur JF. Mediastinal Hibernoma: A Rare Cause of Chronic Cough. Cureus. 2020; 12: e6738. DOI: 10.7759/cureus.6738. PubMed Central
  35. Daubner D, Spieth S, Pablik J, Zöphel K, et al. Hibernoma--Two Patients with a Rare Lipoid Soft-Tissue Tumour. BMC Med Imaging 2015; 15: 4. DOI: 10.1186/s12880-015-0046-3. PubMed
  36. Malzahn J, Kastrenopoulou A, Papadimitriou-Olivgeri I, Papachristou DJ, et al. Immunophenotypic Expression of Ucp1 in Hibernoma and Other Adipose/Non Adipose Soft Tissue Tumours. Clin Sarcoma Res 2019; 9: 8. DOI: 10.1186/s13569-019-0118-1. PubMed
  37. Enterline HT, Lowry LD, Richman AV. Does Malignant Hibernoma Exist? Am J Surg Pathol 1979; 3: 265–71. DOI: 10.1097/00000478-197906000-00009. PubMed

On DermNet

Other websites

Books about skin diseases

 

Related information

Sign up to the newsletter